全文获取类型
收费全文 | 5395篇 |
免费 | 480篇 |
国内免费 | 53篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 114篇 |
妇产科学 | 90篇 |
基础医学 | 864篇 |
口腔科学 | 43篇 |
临床医学 | 610篇 |
内科学 | 1333篇 |
皮肤病学 | 207篇 |
神经病学 | 504篇 |
特种医学 | 280篇 |
外科学 | 486篇 |
综合类 | 80篇 |
一般理论 | 2篇 |
预防医学 | 622篇 |
眼科学 | 45篇 |
药学 | 340篇 |
中国医学 | 4篇 |
肿瘤学 | 277篇 |
出版年
2023年 | 31篇 |
2021年 | 63篇 |
2020年 | 56篇 |
2019年 | 67篇 |
2018年 | 93篇 |
2017年 | 71篇 |
2016年 | 96篇 |
2015年 | 109篇 |
2014年 | 125篇 |
2013年 | 184篇 |
2012年 | 305篇 |
2011年 | 329篇 |
2010年 | 151篇 |
2009年 | 139篇 |
2008年 | 272篇 |
2007年 | 272篇 |
2006年 | 244篇 |
2005年 | 237篇 |
2004年 | 233篇 |
2003年 | 202篇 |
2002年 | 217篇 |
2001年 | 194篇 |
2000年 | 145篇 |
1999年 | 165篇 |
1998年 | 112篇 |
1997年 | 69篇 |
1996年 | 82篇 |
1995年 | 81篇 |
1994年 | 90篇 |
1993年 | 57篇 |
1992年 | 95篇 |
1991年 | 80篇 |
1990年 | 81篇 |
1989年 | 125篇 |
1988年 | 107篇 |
1987年 | 103篇 |
1986年 | 87篇 |
1985年 | 75篇 |
1984年 | 57篇 |
1983年 | 51篇 |
1982年 | 32篇 |
1979年 | 46篇 |
1978年 | 29篇 |
1977年 | 30篇 |
1976年 | 33篇 |
1975年 | 28篇 |
1973年 | 34篇 |
1972年 | 31篇 |
1971年 | 37篇 |
1966年 | 27篇 |
排序方式: 共有5928条查询结果,搜索用时 15 毫秒
11.
S. Caillard C. Lelong F. Pessione B. Moulin for the French PTLD Working Group 《American journal of transplantation》2006,6(11):2735-2742
Post-transplant lymphoproliferative disorders (PTLD) are a rare but serious complication after organ transplantation. A French Registry of PTLD was set up in a nationwide population of kidney transplant recipients. We prospectively enrolled all adult kidney recipients developing PTLD between January 1, 1998, and December 31, 2003. We analyzed the incidence, risk and prognostic factors of PTLD by Kaplan-Meier and Cox analyses. Totally 230 cases of PTLD were referred to the French Registry. Cumulative incidence was 1.18% after 5 years. Older age (per year, AHR = 2.19, CI = 1.22-3.94) and recipient Epstein-Barr virus seronegativity (AHR = 3.01, CI = 1.57-5.08) were associated with an increased risk of PTLD. Patients with PTLD had a reduced survival rate (61% at 5 years). Graft PTLD had the best prognosis with an 81% survival rate after 5 years. Infection with hepatitis C or B virus (HCV or HBV), late-onset PTLD, multiple sites involvement and high Ann Arbor staging were risk factors for patient death. Use of azathioprine was associated with a poorer survival rate. PTLD incidence and risk factors in French recipients are in line with the international or American PTLD series. We highlighted the role of HBV or HCV in patient mortality and described the relevant prognosis factors for patients with post-transplant lymphoproliferations. 相似文献
12.
13.
We describe the results of process mapping of nuclear emergency management procedures in four European countries. We find clear differences and explore these in relation to their suitability for building a shared understanding across the emergency management team of the evolving situation and a balanced appreciation of the uncertainties. Our findings indicate that there are some issues that cause concern in that the procedures may run smoothly and efficiently but they may also risk underestimating uncertainty or ignore key issues that have only been identified by a minority of experts or models. We are concerned that they do not facilitate the building of shared mental models that the literature such as that on highly reliable organisations has shown is important. 相似文献
14.
J Cummings M A Graham B M Hoey J Butler A M Fry I D Hickson G Leonard R French J F Smyth 《Biochemical pharmacology》1992,44(3):433-439
GR63178A (NSC D611615) is the second pentacyclic pyrolloquinone to be evaluated clinically as an anticancer drug. Its mechanism of action is unknown but may be related either to its quinone group or planar ring system. In this report we have investigated the ability of GR63178A to bind non-covalently to DNA, inhibit topoisomerase II and undergo reduction to reactive free radical species. Using two DNA duplexes, a 12-mer oligonucleotide which is a preferred sequence for minor groove binders and a hexamer which is a preferred sequence for intercalators, no evidence of significant binding with GR63178A was found. Neither GR63178A nor GR54374X (its 9-hydroxy metabolite) inhibited purified human topoisomerase II in a decatenation assay. Free radical chemistry was studied by both pulse radiolysis and ESR spectroscopy as well as by in vitro drug incubations with NADPH-fortified rat liver microsomes and purified cytochrome P450 reductase. The one-electron reduction potential of GR63178A was -207 mV +/- 10 which is much more positive than other quinone-containing anticancer drugs such as doxorubicin, mitomycin C and mitozantrone. GR63178A underwent enzyme-catalysed quinone reduction more readily than doxorubicin but produced significantly fewer reactive oxygen species. No evidence was detected of drug-induced, radical-mediated DNA damage in vitro using pBR322 plasmid DNA. Disproportionation of the GR63178A semi-quinone free radical proceeded with a rate constant of 1 x 10(9) M-1 sec-1 under anaerobic conditions, one order of magnitude faster than doxorubicin. The preferential disproportionation of the semi-quinone may explain our inability to detect a free radical signal by ESR. The hydroquinone of GR63178A was stable and exhibited strong visible absorption with a bathochromic shift of 120 nm over the parent drug. These unusual properties may be due to the hydroquinone undergoing a form of keto-enol tautomerization. Thus, GR63178A free radical formation does not appear to result in significant drug activation. In conclusion, GR63178A is unlikely to mediate its antitumour activity by DNA binding, topoisomerase II inhibition or free radical formation in direct contrast to similar anthracycline- and anthraquinone-based anticancer drugs. 相似文献
15.
16.
Petra Mullner Simon E.F. Spencer Daniel J. Wilson Geoff Jones Alasdair D. Noble Anne C. Midwinter Julie M. Collins-Emerson Philip Carter Steve Hathaway Nigel P. French 《Infection, genetics and evolution》2009,9(6):1311-1319
Integrated surveillance of infectious multi-source diseases using a combination of epidemiology, ecology, genetics and evolution can provide a valuable risk-based approach for the control of important human pathogens. This includes a better understanding of transmission routes and the impact of human activities on the emergence of zoonoses. Until recently New Zealand had extraordinarily high and increasing rates of notified human campylobacteriosis, and our limited understanding of the source of these infections was hindering efforts to control this disease. Genetic and epidemiological modeling of a 3-year dataset comprising multilocus sequence typed isolates from human clinical cases, coupled with concurrent data on food and environmental sources, enabled us to estimate the relative importance of different sources of human disease. Our studies provided evidence that poultry was the leading cause of human campylobacteriosis in New Zealand, causing an estimated 58–76% of cases with widely varying contributions by individual poultry suppliers. These findings influenced national policy and, after the implementation of poultry industry-specific interventions, a dramatic decline in human notified cases was observed in 2008. The comparative-modeling and molecular sentinel surveillance approach proposed in this study provides new opportunities for the management of zoonotic diseases. 相似文献
17.
石杉碱甲类似物的研究II.N-甲基吡啶酮石杉碱甲类似物的合成 总被引:4,自引:1,他引:3
石杉碱甲(1)是从中草药石杉属植物千层塔(Lycopodium serratum Thunb.)中分得的一种高效可逆的乙酰胆碱酯酶抑制剂,临床试验证实它对早老性痴呆症有显著疗效。本文报道N-甲基吡啶酮石杉碱甲类似物2和3的合成。2-甲氧基-5-甲氧羰基-11-亚甲基-5,9-甲撑环辛-7-烯并吡啶(9)在乙腈中用三甲基氯硅烷和碘化钠选择性脱保护以定量的产率得吡啶酮10,再用甲醇钠和碘甲烷甲基化得N-甲基吡啶酮11,11经碱性水解,Curtius重排和氨基的脱保护得N-甲基吡啶酮石杉碱甲类似物2。通过类似的途径从中间体2-甲氧基-5-甲氧羰基-7-甲基-11-酮-5,9-甲撑环辛-7-烯并吡啶(14)合成了类似物3。类似物2和3的乙酰胆碱酯酶抑制活性均低于天然石杉碱甲。 相似文献
18.
French Donna L. Häglund Bert O. Himmelstein Kenneth J. Mauger John W. 《Pharmaceutical research》1995,12(10):1513-1520
Purpose. The objective of this study is to correlate drug release mechanism with measured drug concentration profiles in gel layers of Carbopol® matrices containing mesalamine or benzoic acid.
Methods. Release rate experiments with Carbopol® matrices were performed using a rotating disk apparatus. Matrices were frozen and the gel layer in the matrices was sliced using a microtome in a cryostat. Drug concentration profiles were determined by direct measurement of the concentration of the drug in the gel slices. The pH of the slices was measured using microelectrodes, and water content was measured by Karl Fisher titration.
Results. The concentration gradient in mesalamine matrices decreased over time and correlated with square root of time release rate kinetics. The concentration profiles of benzoic acid were unchanged over time and correlated with zero order release rate kinetics. Carbopol gel layers were highly hydrated (93–95% water). Gel layers in matrices with mesalamine had a more alkaline microenvironmental pH. This higher pH resulted in increased growth of the thickness of the gel layer and a reduction drug diffusivity in comparison to benzoic acid matrices.
Conclusions. The release rate kinetics of mesalamine and benzoic acid correlated to the measured concentration profiles. The shape of the concentration profiles is determined by the rate of growth of the Carbopol® gel layer and drug diffusivity. 相似文献
19.
20.